Clinical Infectious Diseases · 1993 · 57 citations · 7 references
MedicineInfectious DiseasesPharmacotherapyKidney TransplantationTransplant PharmacotherapyTransplant SurgeryImmunosuppression In Kidney TransplantationTransplant RejectionAntileishmanial TreatmentCombination TherapyInfection After TransplantationLeishmaniasis PathogenesisPost-transplant ImmunosuppressionRenal Transplant CareTreatment Of LeishmaniasisVisceral Leishmaniasis
A case of a renal transplant recipient who developed pancreatitis during stibogluconate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported. The features of this case are compared with those of the three previously reported cases of pancreatitis during stibogluconate treatment. Complete cure was achieved during the follow-up period of 15 months. If stibogluconate is used for treatment of renal transplant recipients, we advise extreme caution with close observation and combination therapy to be considered instead.
7
Visceral leishmaniasis in immunocompromised hosts
Manuel L. Fernández-Guerrero, JoséM. Aguado, Luís Buzón et al. · The American Journal of Medicine · 1987 · 205 citations
Liposomal amphotericin B in drug-resistant visceral leishmaniasis
R.N. Davidson, Andrew M. Scott, Mala K. Maini et al. · The Lancet · 1991 · 185 citations
A.D.M. Bryceson, J D Chulay, M. Mugambi et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1985 · 92 citations